Narivent is indicated for the:

• reduction of nasal obstruction in patients affected by nasal turbinate hypertrophy and by specific (allergic rhinitis) or non-specific vasomotor rhinitis;

• treatment of oedema associated with acute and chronic rhinosinusal and adenoid inflammatory conditions;

• treatment and prevention of post-surgical relapse of nasal polyps;

• pre- and post-surgical treatment of nasal and rhinosinusal pathologies.